StenlakeJB, WaighRD, DewarGHel al.Biodegradable neuromuscular blocking agents. Part 6. Stereochemical studies on atracurium and related polyalkylene di-esters. Eur J Med Chem1984; 19:441–450.
4.
SavageDS, SleighT, CarlyleIC. The emergence of ORG NC 45 1-[(2b, 3a, 5a, 16b, 17b)-3,17-bis (acetoxy)-2-(1-pipe ridynl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series. Br J Anaesth1980; 52:3S–6S.
5.
MillerRD, RuppSM, FisherDM, CronellyR, FaheyMR, SohnYJ. Clinical pharmacology of vecuronium and atracurium. Anesthesiology1984; 51:444–453.
6.
NagashimaH, YunH, RadnayPA, DuncalfD, KaplanR, FoldesFF. Influence of anesthesia on human dose-response of ORG-NC45. Anesthesiology1981; 55:A202.
7.
GramstadL, LilleaasenP.Clinical comparison of vecuronium, atracurium and pancuronium: A short communication. In Clinical Experiences with Norcuron, AgostonS, BowmanWC, MillerRD, Viby-MogensenJ eds. Excerpta Medica, Amsterdam1983; 140–144.
8.
BastaSJ, AliHH, SavareseJJ, SunderN, GionfriddoM, CloutierG, LineberryC, CatoAE. Clinical pharmacology of atracurium besylate (BW 33A): A new non-depolarizing muscle relaxant. Anesth Analg1982; 61:723–729.
9.
AmakiY, WaudBE, WaudDR. Atracurium-receptor kinetics: simple behavior from a mixture. Anesth Analg1985; 64:777–780.
10.
NoldgeG, HinksenH, BuzelloW.Comparison between continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium. Br J Anaesth1984; 56:473–477.
11.
EagarBM, FlynnPJ, HughesR.Infusion of atracurium for long surgical procedures. Br J Anaesth1984; 56:447–452.
PayneJP, HughesR.Evaluation of atracurium in anaesthetised man. Br J Anaesth1981; 53:45–54.
14.
ScottRPF, GoatVA. Atracurium: Its speed of onset. A comparison with suxamethonium. Br J Anaesth1982; 54:909–911.
15.
HealyTEJ, PughND, KayB, SivalinghamT, PettsHV. Atracurium and vecuronium: Effect of dose on the time of onset. Br J Anaesth1986; 58:620–624.
16.
AliHH, SavareseJJ, BastaSJ, SunderN, GionfriddoM.Evaluation of cumulative properties of three new non-depolarising neuromuscular blocking drugs BW A444U, Atracurium and Vecuronium. Br J Anaesth1983; 55:107S–111S.
17.
BuzelloW, NoldgeG.Repetitive administration of pancuronium and vecuronium (Org NC 45, Norcuron) in patients undergoing long lasting operations. Br J Anaesth1982; 54:1151–1157.
18.
HughesR, ChappleDJ. Effects of non-depolarising neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth1976; 48:59–64.
19.
SutherlandGA, SquireIB, GibbAJ, MarshallIG. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetised cat. Br J Anaesth1983; 55:1119–1126.
20.
MarshallIG, GibbAJ, DurantNN. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, vecuronium (Org NC45) and its potential metabolites in the anaesthetised cat. Br J Anaesth1983; 55:703–714.
21.
BastaSJ, SavareseJJ, AliHH, SunderN, MossJ, GiofriddoM, EmbreeP.Vecuronium does not alter serum histamine within the clinical dose range. Anesthesiology1983; 59:A273.
22.
EngbaekJ, OrdingH, SorensenB, Viby-MogensenJ.Cardiac effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth1983; 55:501–505.
23.
MorrisRB, CahalanMK, MillerRD, WilkinsonPL, QuashaAL, RobinsonSL. The cardiovascular effects of vecuronium (Org NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology1983; 58:428–440.
24.
RobertsonEN, BooijLH, FragenRJ, CrulJF. Clinical comparison of atracurium and vecuronium (Org NC45). Br J Anaesth1983; 55:125–129.
25.
BastaSJ, SavareseJJ, AliHH, MossJ, GiofriddoM.Histamine releasing potencies of atracurium besylate (BW33A) metocurine and d-tubocurarine. Anesthesiology1982; 57:A261.
26.
RuppSM, FaheyMR, MillerRD. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane. Anesthesiology1985; 63:16–19.
27.
SokollMD, GergisSD, MehtaM, KemmotsuO, RuddD.Haemodynamic effects of atracurium in surgical patients under nitrous oxide, oxygen and isoflurane anaesthesia. Br J Anaesth1983; 55:77S–79S.
28.
BarnesPK, ThomasVJE, BoydI, HollwayT.Comparison of the effects of atracurium and tubocurarine on heart rate and arterial pressure in anesthetised man. Br J Anaesth1983; 55:91S–94S.
29.
ShiWZ, FaheyMR, FisherDM, MillerRD, CanfellC, EgerEI. Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits. Anesthesiology1985; 63:589–597.
30.
LanierWL, MildeJH, MichenfelderJD. The cerebral effects of pancuronium and atracurium in halothane anaesthetised dogs. Anesthesiology1985; 63:589–597.
31.
FaheyMR, RuppSM, CanfellCHennisPJ. Effect of renal failure on laudanosine excretion in man. Br J Anaesth1985; 57:1049–1051.
32.
GriffithsRB, HunterJM, JonesRS. Atracurium infusions in patients with renal failure on an ITU. Anaesthesia1986; 41:375–381.
33.
MercierJ, MercierE.Action de quelque ikaloides secondaire de l'opium sur l'electrocorticogramme du chien. C R Soc Biol (Paris)1955; 149:760–762.
34.
IngramMD, SclabassiRJ, CookDR, StillerRL, BennettMH. Cardiovascular and electroencephalographic effects of laudanosine in ‘nephrectomised’ cats. Br J Anaesth1986; 58:14S–18S.
35.
WoodsI, MorrisP, MeakinG.Severe bronchospasm following the use of atracurium in children. Anaesthesia1985; 40207–208.
36.
AldreteJA. Allergic reaction after atracurium. Br J Anaesth1985; 75:929–930.
37.
LaveryGG, BoyleMM, MirakhurRK. Probable histamine liberation with atracurium. A case report. Br J Anaesth1985; 57:811–813.
38.
SrivastavaS.Angioneurotic oedema following atracurium. Br J Anaesth1984; 56:932–933.
39.
WatkinsJ.Adverse anaesthetic reactions. An update from a proposed national reporting and advisory service. Anaesthesia1985; 40:797–800.
40.
ScottRP, SavareseJJ, BastaSJ, SunderN, AliHH. Atracurium: Clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth1985; 57:550–553.
41.
GalletlyDC, TreurenBC. Cutaneous sensitivity to atracurium and vecuronium in patients suffering anaphylactoid reactions to neuromuscular blockers. Anaesth Intens Care1985; 13:305–310.
42.
LaveryGG, HewittAJ, KennyNT. Possible histamine release after vecuronium. Anaesthesia1985; 40:389–340.
43.
SpenceAG, BarnetsonRS. Reaction to vecuronium bromide. Lancet1985; i:979–980.
44.
ClaytonDG, WatkinsJ.Histamine release with vecuronium. Anaesthesia1984; 39:1143–1144.
45.
HarleDG, BaldoBA, FisherMM. Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anaesth1985; 57:1073–1076.
46.
HughesR.Atracurium: An overview. Br J Anaesth1986; 58:2S–5S.
47.
ChappleDJ, ClarkJS. Pharmacological action of breakdown products of atracurium and related substances. Br J Anaesth1983; 55:11S–16S.
48.
MerettRA, ThompsonCW, WebbFW. In vitro degradation of atracurium in human plasma. Br J Anaesth1983; 55:61–66.
49.
StillerRL, CookDR, ChakravortiS.In vitro degradation of atracurium in human plasma. Br J Anaesth1985; 57:1085–1088.
50.
NigrovicV, AuenM, WajskolA.Enzymatic hydrolysis of atracurium in vivo. Anesthesiology1985; 62:606–609.
51.
NigrovicV, PandyaJB, AuenM, WajskolA.Inactivation of atracurium in human and rat plasma. Anesth Analg1985; 64:1047–1052.
52.
FoldesFF, DeeriA.Protein binding of atracurium and other short acting neuromuscular blocking agents and their interaction with human cholinesterases. Br J Anaesth1983; 55:31S–34S.
53.
BenciniA.Clinical pharmacokinetics of vecuronium bromide. In Clinical Experiences with Norcuron. AgostonS, ed. Excerpta Medica, Amsterdam1982; 25–37.
54.
BenciniAF, ScafAHJ, AgostonS, HouwertjesMC, KerstenUW. Disposition of vecuronium bromide in the cat. Br J Anaesth1985; 57:782–788.
55.
WeatherleyBC, WilliamsSG, NeillEAM. Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v. Br J Anaesth1983; 55:39S–46S.
56.
FaheyMR, RuppSM, FisherDMThe pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology1984; 61:699–704.
57.
WardS, NeillEA. Pharmacokinetics of atracurium in acute liver failure (with acute renal failure). Br J Anaesth1983; 55:1169–1175.
58.
BenciniA, ScafAHJ, SohnYJ, KerstenU, AgostonS.Clinical pharmacokinetics of vecuronium. In clinical experiences with vecuronium. AgostonS, BowmanEC, MillerRD, Viby-MogensenJ, eds. Excerpta Medica, Amsterdam1983; 115–123.
59.
LebraultC, BergerJL, D'HollanderAA, GomeniR, HenzelD, DuvaldestinP.Pharmacokinetics of vecuronium (Org NC45) in patients with cirrhosis. Anesthesiology1985; 62:601–605.
60.
GramstaadL, LilleaasenP, MinsaasBB. Comparative study of atracurium, vecuronium (Org NC45) and pancuronium. Br J Anaesth1983; 55:95S–96S.
61.
FoldesFF, NagashimaH, BorosM, TassonyE, FitzalS, AgostonS.Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia. Br J Anaesth1983; 55:97S–103S.
62.
RuppSM, McChristianJW, MillerRD. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans. Anesthesiology1985; 63:16–19.
63.
StirtJA, KatzRL, MurrayAL, SchehlandDL, LeeC.Modification of atracurium blockade by halothane and by suxamethonium. Br J Anaesth1983; 55:71S–75S.
64.
RuppSM, MillerRD, GencarelliPJ. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane and halothane anesthesia in humans. Anesthesiology1984; 60:102–105.
65.
FoldesFF, NagashimaH, OhtaVModification of the neuromuscular blocking effect of vecuronium by various anesthetic agents. In clinical experiences with vecuronium. AgostonS, BowmanWC, MillerRD, Viby-MogensenJ, eds. Excerpta Medica, Amsterdam1983; 132–139.
66.
KriekN, HendrixHHL, CrulJ.Influence of suxamethonium on the potency of Org NC45 in anaesthetised patients. Br J Anaesth1981; 53:259–262.
67.
D'HollanderAA, AgostonS, De VilleA, CuvelierF.Clinical and pharmacological actions of a bolus injection of suxamethonium. Two phenomena of distinct duration. Br J Anaesth1983; 55:131–134.
68.
FisherDM, MillerRD. Interaction of succinylcholine and vecuronium during N2O-halothane anesthesia. Anesthesiology1983; 59:A278.
69.
SokollMD, GergisSD, MehtaM, AliNM, LinberryC.Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia. Anesthesiology1983; 58:450–455.
70.
ManchikantiL, GrowJB, ColliverJA, CanellaMG, HadleyCH. Atracurium pretreatment for succinylcholine-induced fasciculations and postoperative myalgia. Anesth Analg1985; 64:1010–1014.
71.
BuddA, ScottRF, BloggCE, GoatVA. Adverse effects of suxamethonium. Failure of prevention by atracurium or fazadinium. Anaesthesia1985; 40:642–646.
FerresCJ, MirakhurRK, CraigHJ, BrowneES, ClarkeRS. Pretreatment with vecuronium as a prophylactic against post-suxamethonium muscle pain. Comparison with other non-depolarising neuromuscular blocking drugs. Br J Anaesth1983; 55:735–741.
74.
FisherDM, MillerRD. Neuromuscular effects of vecuronium (Org NC45) in infants and children during N2O, halothane anesthesia. Anesthesiology1983; 58:519–523.
75.
GoudsouzianNG, MrtynJJA, LiuLMP, GionfriddoM.Safety and efficacy of vecuronium in adolescents and children. Anesth Analg1983; 62:1083–1088.
76.
GoudsouzianNG, LiuLMP, CoteCJ. Gionfriddo M, Rudd GD. Safety and efficacy of atracurium in adolescents and children anesthetised with halothane. Anesthesiology1983; 59:459–462.
77.
RuppSM, FisherDM, MillerRD, CastagnoliK.Pharmacokinetics and pharmacodynamics of vecuronium in the elderly. Anesthesiology1983; 59:A270.
78.
D'HollanderAA, MassauxF, NevelsteenM, AgostonS.Age dependent dose-response relationship of Org NC45 in anaesthetised patients. Br J Anaesth1982; 54:653–657.
79.
D'HollanderAA. Luyckx C, Barvais L, De Ville A. Clinical evaluation of atracurium besylate requirement for a stable muscle relaxation during surgery: Lack of age-related effects. Anesthesiology1983; 59:237–240.
80.
GyasiHK, NaguibM, Adu-GyamfiY.Atracurium for short surgical procedures: A comparison with succinylcholine. Can Anaesth Soc J1985; 32:613–617.
81.
StirtJA, KatzRL, ShehlDL, LeeC.Atracurium for intubation in man. A clinical and electromyographic study. Anaesthesia1984; 39:1214–1221.
NagashimaH, KaplanH, YunH, NguyenHD, DuncalfD, FoldesFF. Clinical pharmacology of vecuronium: a comparison with pancuronium. In: Clinical Experiences with Norcuron. AgostonS, BowmanWC, MillerRD, Viby-MogensenJ, eds. Excerpta Medica, Amsterdam1983; 127–131.
84.
KriekN, MazurL, BooijLHDJ, CrulJF. Intubating conditions and reversibility of a new nondepolarizing neuromuscular blocking agent Org NC45. Acta Anaesth Scand1980; 24:423–425.
85.
CrulJF. Depolarising and nondepolarising muscle relaxants for endotracheal intubation. In Clinical Experiences with Norcuron. AgostonS, ed. Excerpta Medica, Amsterdam1982; 54–59.
86.
MorrisRB, CahalanMK, MillerRD, WilkinsonPL, QuashaAL, RobinsonSL. The cardiovascular effects of vecuronium (Org NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology1983; 58:438–440.
87.
SalmenperraM, PeltolaK, TakkunenO, HeinonenJ.Cardiovascular effects of pancuronium and vecuronium during high dose fentanyl anaesthesia. Anesth Analg1983; 62:1059–1064.
88.
PhilbinDM, MachajVR, TomichekRC, SchneiderRC, AlbanJC, LowensteinE, LinberryCC. Haemodynamic effects of bolus injections of atracurium in patients with coronary artery disease. Br J Anaesth1983; 55:131S–134S.
89.
WardS, NeillEAM. Pharmacokinetics of atracurium in acute liver failure (with acute renal failure). Br J Anaesth1983; 55:1169–1172.
90.
HunterJM, ParkerCJR, BellCF, JonesRS, UttingJE. The use of different doses of vecuronium in patients with liver dysfunction. Br J Anaesth1985; 57:758–764.
91.
DemetriouM, DepoixJP, DaikiteB, FromentinM, DuvaldestinP.Placental transfer of Org NC45 in women undergoing caesarean section. Br J Anaesth1982; 54:643–645.
92.
FlynnPJ, FrankM, HughesR.Use of atracurium in caesarean section. Br J Anaesth1984; 56:599–605.
93.
SiaRL, RashkowskiOM. Org NC45 and intraocular pressure during anaesthesia. Acta Anaesth Scand1981; 25:219–223.
94.
VilardiV, SanfilippoM, PelaiaP, GasparettoA.The effect of vecuronium on intraocular pressure during anaesthesia. In Clinical Experiences with Norcuron. AgostonS, BowmanWC, MillerRD, Viby-MogensenJ, eds. Excerpta Medica, Amsterdam1983; 163–16.
95.
MintonMD, StirtJA, BedfordRD, HaworthC.Intracranial pressure after atracurium in neurosurgical patients. Anesth Analg1985; 64:1113–1116.
96.
ForrestAL. Atracurium and phaeochromocytoma (letter). Anesth Analg1986; 65:211.
97.
NightingaleP, HealyTE, McGuinessK.Dystrophia myotonica and atracurium. A case report. Br J Anaesth1985; 57:1131–1135.
98.
BellCF, FlorenceAM, HunterJM, JonesRS, UttingJE. Atracurium in the myasthenic patient. Anesthesia1984; 39:961–968.
99.
HarrisMN. Anaesthesia, atracurium and Huntington's chorea. Anaesthesia1984; 39:66.
100.
MichelPA, FronefieldHP. Use of atracurium in a patient susceptible to malignant hyperthermia. Anesthesiology1985; 62:213.
101.
PeltonCI. Vecuronium in myasthenia gravis (letter). Anaesthesia1985; 40:82–83.
